← Back to episode
Metastatic MelanomaAccuracy 3.5/5

Madeline: Stage 4 Melanoma With Lung Lesion and T-Cell Therapy Debate

Madeline appears like a healthy track runner, but her hemoptysis reveals metastatic melanoma.

In Plain English

Madeline's fitness does not protect her from advanced cancer; her healthy baseline only hides the symptoms longer.

What Happened in the Episode

The team debates whether to offer an aggressive immune-based therapy that could help but may also make her very sick.

Clinical Concept

Metastatic melanoma, lung lesion, hemoptysis, stage 4 cancer, immunotherapy, T-cell therapy, surgery, prognosis, and shared decision-making.

What ER Teams Would Evaluate

A real team would biopsy, stage, test tumor mutations, evaluate lung bleeding, review clinical-trial eligibility, and discuss goals of care.

Treatment and Management Overview

Management may include surgery for selected lesions, checkpoint inhibitors, targeted therapy if mutation-positive, cellular therapy in selected contexts, and palliative support.

What TV Gets Right

The episode shows that patient preference matters when treatment is risky and prognosis is poor.

What TV Compresses

It compresses oncology workup, trial consent, drug procurement, and toxicity monitoring.

Sources and Further Reading